Individuals with stable angina will often have a subacute versus chronic presentation. It is important to use history and physical as a screening tool to identify high-risk individuals.

Routine screening of blood pressure, weight, sleep habits, stress, exercise tolerance, tobacco, alcohol, and illicit drug use should be incorporated.

As previously mentioned, typical angina usually presents as chest discomfort or anginal equivalent that is provoked with exertion and alleviated at rest or with nitroglycerin. Anginal equivalents vary, however, commonly can be described as shortness of breath, nausea, or fatigue that is out of proportion to the activity level. 

It is important to distinguish between cardiac and non-cardiac chest discomfort. Discussing the details of the patient’s symptoms will further guide this differentiation. Relevant details include the quality, location, influencing factors, timing, and duration of the pain.[9]

Typical angina is often described as pressure-like, heaviness, tightness, or squeezing. Most commonly, it will affect a broad area of the chest rather than a specific spot. There may be radiation of the pain, depending on which dermatomes are affected.[10][11] Symptoms will be described as more severe with states of increased demand (i.e., walking, lifting, emotional stress, etc.) Symptoms generally last for two to five minutes, and relief is experienced when the provoking activity is stopped, or the patient takes nitroglycerin.[9]

The physical exam is most commonly unremarkable. You would not expect active ischemia in the setting of typical angina, leading to nonspecific physical exam findings. 

Obtain an electrocardiogram to evaluate for active ischemia or evidence of previous infarction. 

Obtain a chest x-ray to assist in ruling out noncardiac explanations for chest pain (i.e., infection, trauma, pneumothorax, etc.)

Obtain a complete blood count, comprehensive metabolic panel, lipid panel, and troponin. Lab work is important in risk stratification purposes and ruling out noncardiac explanations (i.e., anemia, infection, renal disease, etc.)

Use previous work up to risk stratify, consider stress testing versus further coronary evaluation in moderate to high-risk individuals. 

Treatment for stable angina is geared toward reducing risk factors for presumed underlying coronary heart disease. An interdisciplinary approach would likely benefit individuals with multiple comorbidities; nutrition, diabetic educator, addiction counselor, physical and occupational therapy. 

First-line Treatment Includes Lifestyle Modifications

• Tobacco cessation will result in the biggest risk reduction. 
  • Cigarette smoking is the leading avoidable cause of premature death. The risk of cardiovascular mortality in current smokers is roughly two times that of nonsmokers. Interestingly enough, the risk of cardiovascular mortality in former smokers is roughly equal to that of individuals who have never smoked. That said, it is imperative to continuously encourage smoking cessation regardless of age or duration of smoking history[12]
• Cholesterol reduction
  • Evidence has supported that adherence to the Mediterranian diet (high in vegetables and fruits) reduces the risk of cardiovascular disease.[13]
• Blood pressure control
  • The 2017 AHA/ACC guidelines define hypertension as systolic blood pressure ≥130 mmHg or diastolic pressure ≥80 mmHg.[14] Goal blood pressure will be unique to each patient; however, it is important to keep in mind that for each 20/10 mmHg increase in systolic/diastolic blood pressure, evidence has supported a two-fold increased risk of coronary heart and stroke-related mortality.[15]
• Diabetes mellitus management
  • Recommend weight reduction, increased physical activity, and adequate control of comorbidities.[16]
• Weight loss
  • Obesity is the second leading modifiable cause of premature deaths.[17] Weight-loss regimens should be catered to each patient, and the discussion should include lifestyle modifications and surgical options if appropriate. 
• Aerobic exercise
  • An average of 150 minutes of moderate-intensity exercise per week or 75 minutes of high-intensity exercise per week has been shown to decrease overall cardiac risk factors and, in turn, decrease the risk of coronary heart disease.[18]

Pharmacologic

• Aspirin: Determine the risk of coronary heart disease in each patient. In low-risk individuals, the use of aspirin for primary prevention decreases the risk of nonfatal MI without benefit in all-cause mortality and nonfatal stroke.[19] Risk stratification is important as the use of aspirin comes with an increased risk of major bleeding.[20] Extracranial bleeding is the most common, however daily low-dose aspirin does increase the risk of intracranial hemorrhage as well.[21] As there is no evidence to support a mortality benefit for the use of aspirin in low-risk individuals, the risk of bleeding may outweigh the anticipated benefit. This should be decided on a case by case basis. High-risk individuals or individuals with known cardiovascular disease benefit from low dose daily aspirin. According to the meta-analysis performed by the Antithrombotic Trialists' Collaboration, daily aspirin significantly reduced the risk of nonfatal MI, nonfatal stroke, and vascular death by 22%.[22]
• HMG-CoA reductase inhibitor: Statin therapy in high, moderate, and low-risk primary prevention subjects without clinical evidence of coronary disease has demonstrated a reduction in myocardial infarction, stroke, cardiovascular death, and total mortality.[23]
• ACE-inhibitor/angiotensin receptor blocker (ARB): May be used in primary prevention to assist in blood pressure control and recommended in the setting of high-risk individuals or known cardiovascular disease for cardioprotective efforts. The use of ACE-inhibitors or ARBs in high-risk individuals has been shown to reduce the risk of cardiovascular and all-cause mortality.[24]

• Symptom Control
  • Beta-blockers: Beta-blockers have been shown to decrease heart rate, blood pressure, and contractility, ultimately leading to decreased myocardial oxygen demand and decreasing anginal symptoms.[25]
  • Nitrates: Nitrates relax vascular smooth muscle leading to dilation of veins primarily; this decreases cardiac preload and, in turn, decreases myocardial oxygen demand providing relief in anginal symptoms.[26]
  • Ranolazine: The mechanism of action of this medication is not entirely understood; however, it is FDA approved for symptom control in stable angina.[27]  

Listed below are several important differential diagnoses to consider. Brief details are listed next to each diagnosis to help differentiate from stable angina - for specific details and diagnostic criteria for each differential diagnosis, please reference their designated articles.

Cardiovascular

• Acute coronary syndrome
• Unstable angina: Detailed history is pertinent. Chest pain less likely to follow a predictable pattern, and the patient may even experience chest pain at rest.
• NSTEMI: Elevated cardiac enzymes with or without EKG changes.
• STEMI: Elevated cardiac enzymes with regional ST elevations noted on EKG.
• Myocarditis: Elevated cardiac enzymes with EKG changes.
• Pericarditis: Diffuse ST elevations noted on EKG with or without an elevation in cardiac enzymes. Chest pain is pleuritic and is often relieved with leaning forward. 

Gastrointestinal

• Esophageal spasm: Temporal relationship to meals with or without dysphagia
• Gastroesophageal reflux disease: Temporal relationship to meals

Pulmonary 

• Asthma: Abnormal lung sounds expected on the exam. Anticipate improvement in symptoms with pulmonary hygiene and inhaled beta-agonists. 
• Chronic obstructive pulmonary disease: Abnormal lung sounds expected on the exam. Anticipate improvement in symptoms with pulmonary hygiene and inhaled beta-agonists. 
• Pulmonary embolus: Chest pain pleuritic in nature. Typically, the presentation includes tachycardia and hypoxemia.

Musculoskeletal 

• Costochondritis: Chest pain reproducible on the exam. History often reveals recent heavy lifting or exercise.
• Trauma: History reveals the mechanism of trauma. Imaging may reveal fractures.

Prognosis varies depending on the etiology of stable angina. In each case, regardless of etiology, aggressive risk factor modification is imperative. In individuals with stable angina, screening for increased frequency of symptoms or transition to unstable angina should be routinely performed. 

The most important complication of stable angina is the possibility of progression to acute coronary syndrome. Risk factor modification and medical optimization should be utilized to decrease risk. These individuals require routine monitoring and attentive primary care providers.

Coronary heart disease is the leading cause of death in the United States, and efforts to educate the public regarding signs and symptoms of myocardial infarction, unstable angina, and stable angina should be continued. Efforts to educate the public regarding preventative measures such as risk factor modification and lifestyle modifications should also be a priority. 

Typical angina affects over 10 million people in the United States. The presentation can vary from chest pressure to fatigue to shortness of breath to nausea. If this ultimately leads to myocardial infarction or unstable angina, the cardiology team is imperative in treatment; however, there are often many providers that will see this individual before that evolution. It is important to utilize an interprofessional team to best suit each patient. The primary care provider will play a large role in primary and secondary prevention, likely for many years prior to the development of symptoms. This provider may also recruit the help of a nutritionist, diabetic educator, addiction counselor, and physical and occupational therapy to help with modifying risk factors. The use of an interdisciplinary team is recommended to optimize patient outcomes.